PMID: 9544439Apr 17, 1998Paper

Resistance of spontaneously transformed Syrian hamster embryo cells and their malignant variants to cytotoxic activity of recombinant tumor necrosis factor-alpha

Cancer Detection and Prevention
E A Volpe

Abstract

To study the possible role of the host macrophages in the selection of tumor cells and tumor progression, a series of Syrian hamster tumor cell lines all originating from a single spontaneously transformed Syrian hamster embryo cell line (STHE strain) have been established. These STHE tumor cell variants, selected either in vitro with resident and lipopolysaccharide-activated macrophages or in vivo, differ in tumorigenic and metastatic activity. The selected malignant STHE cells become resistant to cytotoxic activity of activated peritoneal macrophages and of exogenous hydrogen peroxide (H2O2). Since activated macrophages are a known source for both cytotoxic agents H2O2 and tumor necrosis factor (TNF), the purpose of the present study was to define the sensitivity of the STHE tumor cell lines to a direct cytotoxic activity mediated by recombinant TNF-alpha in an attempt to understand the role of the cytokine in in vitro selection of a malignant STHE cells by activated macrophages. The spontaneously transformed STHE cells (selected in vivo and in vitro) as well as the hamster embryo cells transformed in vitro by a tumorigenic Rous sarcoma virus (Schmidt-Ruppin strain) were used as targets. TNF-alpha-sensitive mouse L929 cells w...Continue Reading

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Sep 1, 1989·Clinical & Experimental Metastasis·L RemelsP De Baetselier
Mar 15, 1986·International Journal of Cancer. Journal International Du Cancer·G I Deichman, E L Vendrov
Jan 1, 1986·Current Topics in Cellular Regulation·J A Badwey, M L Karnovsky
Sep 1, 1988·Journal of Clinical Immunology·H M Shepard, G D Lewis
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J L UrbanH Schreiber
Feb 1, 1987·The Journal of Clinical Investigation·C F Nathan
Mar 15, 1987·International Journal of Cancer. Journal International Du Cancer·L M Remels, P C De Baetselier
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D PennicaD V Goeddel
Oct 1, 1984·British Journal of Cancer·K HaranakaA Sakurai
Mar 30, 1984·Journal of Immunological Methods·D A Flick, G E Gifford
Feb 25, 1983·Journal of Immunological Methods·H Fisch, G E Gifford
Mar 3, 1995·International Journal of Cancer. Journal International Du Cancer·M Jäättelä
May 1, 1993·Research in Immunology·A MantovaniF Colotta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.